{"altmetric_id":2427334,"counts":{"readers":{"mendeley":20,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[57717],"posts_count":1},"total":{"posts_count":1}},"citation":{"abstract":"To investigate group differences, the within-group distributions, and the clinical correlates of platelet serotonin (5-HT) levels in pervasive developmental disorders (PDD).","abstract_source":"pubmed","altmetric_jid":"4f6fa4f63cf058f610002f53","authors":["Mulder EJ","Anderson GM","Kema IP","de Bildt A","van Lang ND","den Boer JA","Minderaa RB"],"doi":"10.1097\/00004583-200404000-00016","first_seen_on":"2014-06-11T15:15:22+00:00","issns":[],"journal":"Journal of the American Academy of Child & Adolescent Psychiatry","last_mentioned_on":1402403400,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15187810"],"pmid":"15187810","pubdate":"2004-01-04T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Psychology And Cognitive Sciences","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Social Sciences","Psychology"],"subjects":["psychiatry","pediatrics"],"title":"Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/platelet-serotonin-levels-pervasive-developmental-disorders-mental-retardation-diagnostic-group-diff-8"},"altmetric_score":{"score":5.104,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.104},"context_for_score":{"all":{"total_number_of_other_articles":3908982,"mean":5.0142013956037,"rank":629951,"this_scored_higher_than_pct":83,"this_scored_higher_than":3277139,"rank_type":"exact","sample_size":3908982,"percentile":83},"similar_age_3m":{"total_number_of_other_articles":97487,"mean":7.4897520311859,"rank":18307,"this_scored_higher_than_pct":81,"this_scored_higher_than":79142,"rank_type":"exact","sample_size":97487,"percentile":81},"this_journal":{"total_number_of_other_articles":967,"mean":8.204,"rank":274,"this_scored_higher_than_pct":70,"this_scored_higher_than":686,"rank_type":"exact","sample_size":967,"percentile":70},"similar_age_this_journal_3m":{"total_number_of_other_articles":14,"mean":17.422461538462,"rank":8,"this_scored_higher_than_pct":28,"this_scored_higher_than":4,"rank_type":"exact","sample_size":14,"percentile":28}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Doctoral Student":3,"Researcher":3,"Student  > Ph. D. Student":4,"Student  > Postgraduate":1,"Student  > Master":3,"Student  > Bachelor":3,"Professor":1},"by_discipline":{"Medicine and Dentistry":7,"Social Sciences":2,"Psychology":6,"Agricultural and Biological Sciences":4,"Biochemistry, Genetics and Molecular Biology":1}}}},"posts":{"blogs":[{"title":"How to evaluate new medications for autism","url":"https:\/\/sfari.org\/news-and-opinion\/viewpoint\/2014\/how-to-evaluate-new-medications-for-autism","citation_ids":[2313259,899742,1124212,119068,168988,682209,682175,376082,173431,525505,104018,2427333,692748,457564,2211636,2179704,511998,391643,2427334],"posted_on":"2014-06-10T12:30:00+00:00","summary":"Julia Yellow\r\nLong quest: In finding treatments for autism, scientists must grapple with autism&rsquo;s enormous diversity.\n                                    There are just two","author":{"name":"SFARI.org - Simons Foundation Autism Research Initiative","url":"https:\/\/sfari.org\/","description":"Autism research news and opinion, funding opportunities and program information"}}]}}